268 related articles for article (PubMed ID: 24286519)
1. CD56+ monocytes have a dysregulated cytokine response to lipopolysaccharide and accumulate in rheumatoid arthritis and immunosenescence.
Krasselt M; Baerwald C; Wagner U; Rossol M
Arthritis Res Ther; 2013 Oct; 15(5):R139. PubMed ID: 24286519
[TBL] [Abstract][Full Text] [Related]
2. Effects of TNF inhibitor on innate inflammatory and Th17 cytokines in stimulated whole blood from rheumatoid arthritis patients.
Zivojinovic S; Pejnovic N; Sefik-Bukilica M; Kovacevic L; Soldatovic I; Bugarski D; Mojsilovic S; Damjanov N
Inflammopharmacology; 2012 Dec; 20(6):323-30. PubMed ID: 22733231
[TBL] [Abstract][Full Text] [Related]
3. The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population.
Rossol M; Kraus S; Pierer M; Baerwald C; Wagner U
Arthritis Rheum; 2012 Mar; 64(3):671-7. PubMed ID: 22006178
[TBL] [Abstract][Full Text] [Related]
4. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
5. In vitro response pattern of monocytes after tmTNF reverse signaling predicts response to anti-TNF therapy in rheumatoid arthritis.
Meusch U; Krasselt M; Rossol M; Baerwald C; Klingner M; Wagner U
J Transl Med; 2015 Aug; 13():256. PubMed ID: 26251236
[TBL] [Abstract][Full Text] [Related]
6. FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.
Cooper DL; Martin SG; Robinson JI; Mackie SL; Charles CJ; Nam J; ; Isaacs JD; Emery P; Morgan AW
PLoS One; 2012; 7(1):e28918. PubMed ID: 22235253
[TBL] [Abstract][Full Text] [Related]
7. Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy.
Chen DY; Chen YM; Chen HH; Hsieh CW; Lin CC; Lan JL
Arthritis Res Ther; 2011 Jul; 13(4):R126. PubMed ID: 21801431
[TBL] [Abstract][Full Text] [Related]
8. Functional phenotype of synovial monocytes modulating inflammatory T-cell responses in rheumatoid arthritis (RA).
Yoon BR; Yoo SJ; Choi Yh; Chung YH; Kim J; Yoo IS; Kang SW; Lee WW
PLoS One; 2014; 9(10):e109775. PubMed ID: 25329467
[TBL] [Abstract][Full Text] [Related]
9. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.
Walter GJ; Evans HG; Menon B; Gullick NJ; Kirkham BW; Cope AP; Geissmann F; Taams LS
Arthritis Rheum; 2013 Mar; 65(3):627-38. PubMed ID: 23280063
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
[TBL] [Abstract][Full Text] [Related]
11. The pro-inflammatory phenotype of the human non-classical monocyte subset is attributed to senescence.
Ong SM; Hadadi E; Dang TM; Yeap WH; Tan CT; Ng TP; Larbi A; Wong SC
Cell Death Dis; 2018 Feb; 9(3):266. PubMed ID: 29449647
[TBL] [Abstract][Full Text] [Related]
12. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.
Sebbag M; Parry SL; Brennan FM; Feldmann M
Eur J Immunol; 1997 Mar; 27(3):624-32. PubMed ID: 9079801
[TBL] [Abstract][Full Text] [Related]
13. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
Front Immunol; 2018; 9():2228. PubMed ID: 30319663
[TBL] [Abstract][Full Text] [Related]
14. TLR1/2 and 5 induce elevated cytokine levels from rheumatoid arthritis monocytes independent of ACPA or RF autoantibody status.
Thwaites RS; Unterberger S; Chamberlain G; Walker-Bone K; Davies KA; Sacre S
Rheumatology (Oxford); 2020 Nov; 59(11):3533-3539. PubMed ID: 32594150
[TBL] [Abstract][Full Text] [Related]
15. Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis Are Associated with Autoantibody Status.
Chalan P; Bijzet J; Kroesen BJ; Boots AM; Brouwer E
J Rheumatol; 2016 Jun; 43(6):1008-16. PubMed ID: 27036380
[TBL] [Abstract][Full Text] [Related]
16. Effect of Native and Minimally Modified Low-density Lipoprotein on the Activation of Monocyte Subsets.
Blanco-Favela F; Espinosa-Luna JE; Chávez-Rueda AK; Madrid-Miller A; Chávez-Sánchez L
Arch Med Res; 2017 Jul; 48(5):432-440. PubMed ID: 29133194
[TBL] [Abstract][Full Text] [Related]
17. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.
Hahn G; Stuhlmüller B; Hain N; Kalden JR; Pfizenmaier K; Burmester GR
J Clin Invest; 1993 Mar; 91(3):862-70. PubMed ID: 8450066
[TBL] [Abstract][Full Text] [Related]
18. Deficient spontaneous in vitro apoptosis and increased tmTNF reverse signaling-induced apoptosis of monocytes predict suboptimal therapeutic response of rheumatoid arthritis to TNF inhibition.
Meusch U; Klingner M; Baerwald C; Rossol M; Wagner U
Arthritis Res Ther; 2013; 15(6):R219. PubMed ID: 24354986
[TBL] [Abstract][Full Text] [Related]
19. Cytokine production from stimulated whole blood cultures in rheumatoid arthritis patients treated with various TNF blocking agents.
Popa C; Barrera P; Joosten LA; van Riel PL; Kullberg BJ; van der Meer JW; Netea MG
Eur Cytokine Netw; 2009 Jun; 20(2):88-93. PubMed ID: 19541595
[TBL] [Abstract][Full Text] [Related]
20. Specific overexpression of tumour necrosis factor-α-induced protein (TNFAIP)9 in CD14(+) CD16(-) monocytes in patients with rheumatoid arthritis: comparative analysis with TNFAIP3.
Takai C; Matsumoto I; Inoue A; Umeda N; Tanaka Y; Kurashima Y; Wada Y; Narita I; Sumida T
Clin Exp Immunol; 2015 Jun; 180(3):458-66. PubMed ID: 25683200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
